throbber
Name:
`Date of Birth:
`Place of Birth:
`Citizenship:
`Education:
`1965-1969
`
`1969-1973
`
`
`Positions held:
`1969-1973
`
`1974-1975
`
`1976-1978
`
`1979-1982
`1982-1986
`1986-2019
`
`Honors:
`
`2019-present
`
`
`Professional Activities:
`1980-2011
`1988-1994
`1994-2014
`1987-1992
`1991
`1992-2000
`1994-1998
`1994-1999
`2005-2015
`
`C U R R I C U L U M V I T A E
`
`John Kenneth Rose
`July 21, 1947
`Northampton, Massachusetts
`U.S.
`
`Brandeis University, Waltham, Massachusetts.
`B.A. in Biology
`Stanford University, Stanford, California
`Ph.D. Biology and Biochemical Genetics
`
`Predoctoral trainee of the U.S. Public Health Service
`with Dr. Charles Yanofsky, Stanford University
`Postdoctoral Fellow, Massachusetts Institute of Technology in
`the laboratories of Drs. Harvey Lodish and David Baltimore
`Research Associate, Massachusetts Institute of Technology, with
`Dr. David Baltimore
`Assistant Professor, The Salk Institute
`Associate Professor, The Salk Institute
`Professor of Pathology and Cell Biology
`Yale University School of Medicine
`Emeritus Professor of Pathology, Senior Research Scientist
`Yale University School of Medicine
`
`Editorial Board Member, Journal of Virology
`Editor of Virology for negative-strand RNA viruses
`Editorial Board Member,Virology
`Director of Graduate Studies in Experimental Pathology
`Co-chairman, Gordon Conference on Animal Cells and Viruses
`Director, Yale Medical School HIV research facility
`Member, NIH ARR-1 AIDS Study Section
`Co-director, Yale Graduate Program in Microbiology
`Director, Program in Virology and Vaccine Development, Yale
`University
`Two National Institutes of Health MERIT awards
`
`Page 1 of 17
`
`KELONIA EXHIBIT 1003
`
`

`

`
`Research Interests: Structure and function of viral glycoproteins. Vaccine development
`employing vectors based on recombinant RNA viruses. Specific targeting of viral
`vectors. Assembly of enveloped viruses.
`
`
`
`Publications
`1. Rose, J.K., Mosteller, R.D. & Yanofsky, C. 1970. Tryptophan messenger RNA
`elongation rates and steady state levels of tryptophan operon enzymes under
`various growth conditions. J. Mol. Biol. 51:541-550.
`2. Mosteller, R.D., Rose, J.K. & Yanofsky, C. 1970. Transcription initiation and
`degradation of trp mRNA. Cold Spring Harbor Symp. Quant. Biol. 35:461-466.
`3. Rose, J.K. & Yanofsky, C. 1971. Transcription of the operator proximal and distal
`ends of the tryptophan operon: evidence that trp E and trp A and the delimiting
`structural genes. J. Bacteriol. 108:615-618.
`4. Rose, J.K. & Yanofsky, C. 1972. Metabolic regulation of the tryptophan operon of
`Escherichia coli: Repressor-independent regulation of transcription initiation fre-
`quency. J. Mol. Biol. 69:103-118.
`5. Rose, J.K., Squires, C.L., Yanofsky, C., Yang, H.-L. & Zubay, G. 1973. Regulation of
`in vitro transcription of the tryptophan operon by purified RNA polymerase in the
`presence of partially purified repressor and tryptophan. Nature New Biol. 245:133-
`137.
`6. Squires, C.L., Rose, J.K., Yanofsky, C., Yang, H.-L. & Zubay, G. 1973. Tryptophanyl-
`tRNA and tryptophanyl-tRNA synthetase are not required for in vitro repression of
`the tryptophan operon. Nature New Biol. 245:131-133.
`7. Rose, J.K. & Yanofsky, C. 1974. Interaction of the operator of the tryptophan operon
`with repressor. Proc. Natl. Acad. Sci. USA 71: 3134-3138.
`8. Rose, J.K. & Knipe, D. 1975. Nucleotide sequence complexities, molecular weights
`and poly(A) content of the vesicular stomatitis virus mRNA species. J. Virol. 15:994-
`1003.
`9. Knipe, D., Rose, J.K. & Lodish, H.F. 1975. Translation of individual species of vesic-
`ular stomatitis viral mRNA. J. Virol. 15:1004-1011.
`10. Rose, J.K. 1975. Heterogeneous 5'-terminal structures occur on vesicular stomatitis
`virus mRNAs. J. Biol. Chem. 250:8098-8104.
`11. Hewlett, M.J., Rose, J.K. & Baltimore, D. 1976. 5'-terminal structure of poliovirus
`polyribosomal RNA is pUp. Proc. Natl. Acad. Sci. USA 73:327-330.
`12. Rose, J.K. & Lodish. H.F. 1976. Translation in vitro of vesicular stomatitis virus
`mRNA lacking 5'-terminal 7-methylguanosine. Nature 262:32-37.
`13. Rose, J.K., Hasletine, W.A. & Baltimore, D. 1976. The 5' terminus of Moloney
`murine leukemia virus 35S RNA is m7G5'ppp5'GmpCp. J. Virol. 20:324-329.
`
`Page 2 of 17
`
`

`

`14. Lodish, H.F. & Rose, J.K. 1977. Relative importance of 7-methylguanosine in ribo-
`some binding and translation of vesicular stomatitis virus mRNA in wheat germ
`and reticulocyte cell-free systems. J. Biol. Chem. 252:1181-1188.
`15. Rose, J.K., Lodish, H.F. & Brock, M.L. 1977. Giant heterogeneous poly(A) on vesic-
`ular stomatitis virus mRNA synthesized in vitro in the presence of S-adenosylhomo-
`cysteine. J. Virol. 21:683-693.
`16. Freeman, G.J., Rose, J.K., Clinton, G.M. & Huang, A.S. 1977. RNA synthesis of vesic-
`ular stomatitis virus VII. Complete separation of the messenger RNAs of vesicular
`stomatitis virus by duplex formation. J. Virol. 21:1094-1104.
`17. Rose, J.K. 1977. Nucleotide sequences of ribosome recognition sites in messenger
`RNAs of vesicular stomatitis virus. Proc. Natl. Acad. Sci. USA 74:3672-3676.
`18. Pettersson, R.F., Flanegan, J.B., Rose, J.K. & Baltimore, D. 1977. 5'-terminal nucleo-
`tide sequences of polio virus polyribosomal RNA and virion RNA are identical.
`Nature (London) 268:270-272.
`19. Rose, J.K. 1977. Ribosome recognition sites in vesicular stomatitis virus mRNA. In,
`Negative Strand Viruses and the Host Cell (B.W.J. Mahy & R.D. Barry, eds.),
`Academic Press, New York, pp. 47-61.
`20. Baltimore, D., Pettersson, R.F., Flanegan, J.B., Hewlett, M.J., Rose, J.K. & Ambros, V.
`1978. New structures in viral RNA: Non- covalent circles and covalently-linked
`protein. In, Perspectives in Virology (M. Pollard, ed.), pp. 110-115.
`21. Rose, J.K. 1978. Complete sequences of the ribosome recognition sites in vesicular
`stomatitis virus mRNAs: Recognition by the 40S and 80S complexes. Cell 14:345-
`353.
`22. Rose, J.K., Trachsel, H., Leong, K. & Baltimore, D. 1978. Inhibition of translation by
`poliovirus: Inactivation of a specific initiation factor. Proc. Natl. Acad. Sci. USA
`75:2732-2736.
`23. Rose, J.K. & Iverson, L. 1979. Nucleotide sequences from the 3'-ends of vesicular
`stomatitis virus mRNAs as determined from cloned DNA. J. Virol. 32:404-411.
`24. Rose, J.K. 1980. Ribosome recognition and translation of vesicular stomatitis virus
`messenger RNA. In, Rhabdoviruses (D.H.L. Bishop, ed.), CRC Press, Boca Raton,
`Florida, pp. 51-60.
`25. Trachsel, H., Sonnenberg, N., Shatkin, A.J., Rose, J.K., Leong, K., Bergmann, J.E.,
`Gordon, J. & Baltimore, D. 1980. Purification of a factor that restores translation of
`vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells.
`Proc. Natl. Acad. Sci. USA 77:770-774.
`26. Rose, J.K. 1980. Complete intergenic and flanking gene sequences from the genome
`of vesicular stomatitis virus. Cell 19:415-421.
`27. Rose, J.K., Welch, W.J., Sefton, B.M., Esch, F.S. & Ling, N.C. 1980. Vesicular stomati-
`tis virus glycoprotein is anchored in the viral membrane by a hydrophobic domain
`near the COOH-terminus. Proc. Natl. Acad. Sci. USA 77:3884-3888.
`
`Page 3 of 17
`
`

`

`28. Rose, J.K., Welch, W.J., Sefton, B.M. & Iverson, L.E. 1980. Analysis of VSV glycopro-
`tein structure and genome structure using cloned DNA. In, Animal Virus Genetics
`(B.N. Fields, R. Jaenisch & C.F. Fox, eds.), Academic Press, New York.
`29. Iverson, L.E. & Rose, J.K. 1981. Localized attenuation and discontinuous synthesis
`during vesicular stomatitis virus transcription. Cell 23:477-484.
`30. Rose, J.K., Iverson, L.E., Gallione, C.J. & Greene, J.R. 1981. Vesicular stomatitis virus
`gene structure and transcription attenuation. In, Negative Strand Viruses (D.H.L.
`Bishop & R. Compans, eds.), Elsevier, North Holland, pp. 713-721.
`31. Rose, J.K. & Gallione, C.J. 1981. Nucleotide sequences of the mRNAs encoding the
`vesicular stomatitis virus G and M proteins determined from cDNA clones contain-
`ing the complete coding regions. J. Virol. 39:519-528.
`32. Gallione, C., Greene, J., Iverson, L. & Rose, J.K. 1981. Nucleotide sequences of the
`mRNAs encoding the vesicular stomatitis virus N and NS proteins. J. Virol. 39:529-
`535.
`33. Rose, J.K. & Shafferman, A. 1981. Conditional expression of the vesicular stomatitis
`virus glycoprotein gene in Escherichia coli. Proc. Natl. Acad. Sci. USA 78:6670-6674.
`34. Rose, J.K., Doolittle, R., Anilionis, A., Curtis, P., Wunner, W. 1982. Homology be-
`tween the glycoproteins of vesicular stomatitis virus and rabies virus. J. Virol.
`43:361-364.
`35. Rose, J.K. & Bergmann, J.E. 1982. Expression from cloned cDNA of cell-surface and
`secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells.
`Cell 30:753-762.
`36. Iverson, L.E. & Rose, J.K. 1982. Sequential synthesis of 5'-proximal vesicular stoma-
`titis virus mRNA sequences. J. Virol. 44: 356-365.
`37. Gallione, C.J. & Rose, J.K. 1983. Nucleotide sequence of a cDNA clone encoding the
`entire glycoprotein from the New Jersey serotype of vesicular stomatitis virus. J.
`Virol. 46:162-169.
`38. Rose, J.K. & Bergmann, J.E. 1983. Altered cytoplasmic domains affect intracellular
`transport of the vesicular stomatitis virus glycoprotein. Cell 34:513-524.
`39. Florkiewicz, R.Z., Smith, A., Bergmann, J.E. & Rose, J.K. 1983. Isolation of stable
`mouse cell lines that express cell surface and secreted forms of the vesicular
`stomatitis virus glycoprotein. J. Cell Biol. 97:1381-1388.
`40. Rose, J.K., Adams, G.A. & Gallione, C.J. 1984. The presence of cysteine in the cyto-
`plasmic domain of the vesicular stomatitis virus glycoprotein is required for
`palmitate addition. Proc. Natl. Acad. Sci. USA. 81:2050-2054.
`41. Florkiewicz, R.Z. & Rose, J.K. 1984. A cell line expressing the vesicular stomatitis
`virus glycoprotein fuses at low pH. Science 225:721-723.
`42. Guan, J.-L. & Rose, J.K. 1984. Conversion of a secretory protein into a trans-
`membrane protein results in its transport to the Golgi complex but not to the cell
`surface. Cell 37:779-787.
`
`Page 4 of 17
`
`

`

`43. Gallione, C.J. & Rose, J.K., 1985. A single amino acid substitution in a hydrophobic
`domain causes temperature-sensitive cell-surface transport of a mutant viral glyco-
`protein. J. Virol. 54:374-382.
`44. Moller, J.R., Rager-Zisman, B., Phuc-Cahn, Q., Schattner, A., Panush, D., Rose, J.K.
`& Bloom, B.R. 1985. NK cell recognition of target cells expressing different antigens
`of vesicular stomatitis virus. Proc. Natl. Acad. Sci. U.S.A. 82:2456-2459.
`45. Mackett, M., Yilma, T., Rose, J. & Moss, B., 1985. Vaccinia virus recombinants:
`expression of VSV genes and protective immunization of mice and cattle. Science
`277:433-435.
`46. Adams, G.A. & Rose, J.K. 1985. Incorporation of a charged amino acid into the
`membrane spanning domain blocks cell-surface transport but not membrane-
`anchoring of a viral glycoprotein. Mol. Cell Biol. 5:1442-1448.
`47. Rose, J., Adams, G., Guan, J.-L., Machamer, C. & Puddington, L. 1985. Redesigning
`transport signals in membrane and secretory proteins. (In, Protein Transport and
`Secretion, pp. 7-85; ed. Mary-Jane Gething). Cold Spring Harbor Laboratory Press,
`1985.
`48. Adams, G.A. & Rose, J.K. 1985. Structural requirements of a membrane spanning
`domain for protein anchoring and cell surface transport. Cell 41:1007-1015.
`49. Machamer, C.E., Florkiewicz, R.Z. & Rose, J.K. 1985. A single N-linked oligo-
`saccharide at either of the two normal sites is sufficient for transport of the vesicular
`stomatitis virus G protein to the cell surface. Mol. Cell Biol. 5:3074-3083.
`50. Guan, J.-L., Machamer, C.E. & Rose, J.K. 1985. Glycosylation allows cell-surface
`transport of an anchored secretory protein. Cell 42:489-496.
`51. Rose, J.K. & Schubert, M. 1987. Rhabdovirus Genomes and Their Products. In, The
`Viruses, (eds. R. Wagner & H. Frankel-Conrat) Plenum Press, pp. 129-159.
`52. Machamer, C.E., Guan, J.-L., Florkiewicz, R.Z. & Rose, J.K. 1986. Role of N-linked
`glycosylation in intracellular transport of transmembrane proteins. Microbiology
`(Wash. D.C.) 1986:292-296.
`53. Woodgett, C. & Rose, J.K. 1986. Amino-terminal mutation of the vesicular stomatitis
`virus glycoprotein does not affect its fusion activity. J. Virol. 59:486-489.
`54. Puddington, L., Machamer, C.E. & Rose, J.K. 1986. Cytoplasmic domains of cellular
`and viral integral membrane proteins substitute for the cytoplasmic domain of the
`vesicular stomatitis virus glycoprotein in transport to the plasma membrane. J. Cell
`Biol. 102:2147-2157.
`55. Puddington, L., Bevan, M.J., Rose, J.K. & Lefrançois, L. 1986. N protein is the pre-
`dominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T
`Cells. J. Virol. 60: 708-717.
`56. Puddington, L., Woodgett, C. & Rose, J.K. 1987. Replacement of the cytoplasmic do-
`main alters sorting of a viral glycoprotein in polarized cells. Proc. Natl. Acad. Sci.,
`USA 84:2756-2760.
`
`Page 5 of 17
`
`

`

`57. Scullion, B.F, Hou, Y., Puddington, L., Rose, J.K. & Jacobson, K. 1987. Effects of
`mutations in three domains of the vesicular stomatitis viral glycoprotein on its
`lateral diffusion in the plasma membrane. J. Cell Biol. 105:69-75.
`58. Rottier, P.J.M. & Rose, J.K. 1987. Coronavirus E1 glycoprotein expressed from
`cloned cDNA localizes in the Golgi region. J. Virol. 61:2042-2045.
`59. Rottier, P.J.M., Florkiewicz, R.Z., Shaw, A.S. & Rose, J.K. 1987. An internalized
`amino-terminal signal sequence retains full activity in vivo but not in vitro. J. Biol.
`Chem. 262:8889-8895.
`60. Machamer, C.E. & Rose, J.K. 1987. A specific transmembrane domain of a corona-
`virus E1 glycoprotein is required for its retention in the Golgi region. J. Cell Biol.
`105:1205-1214.
`61. Kupfer, A., Kronebusch, P.J., Rose, J.K. & Singer, S.J. 1987. A critical role for the
`polarization of membrane recycling in cell motility. Cell Motility and the
`Cytoskeleton. 8:182-189.
`62. Guan, J.-L., Çao, H. & Rose, J.K. 1988. Cell-surface expression of a membrane-an-
`chored form of the human chorionic gonadotropin alpha subunit. J. Biol. Chem.
`263:5306-5313.
`63. Fukuda, M., Guan, J.-L. & Rose, J.K. 1988. A membrane-anchored form but not the
`secretory form of human chorionic gonadotropin alpha chain acquires polylactos-
`aminoglycan. J. Biol. Chem. 263:5314-5318.
`64. Machamer, C.E. & Rose, J.K. 1988. Influence of new glycosylation sites on expres-
`sion of the vesicular stomatitis virus G protein at the plasma membrane. J. Biol.
`Chem. 263:5948-5954.
`65. Machamer, C.E. & Rose, J.K. 1988. Vesicular stomatitis virus G proteins with altered
`glycosylation sites display temperature-sensitive intracellular transport and are
`subject to aberrant intermolecular disulfide bonding. J. Biol. Chem. 263:5955-5960.
`66. Doms, R.W., Ruusala, A., Machamer, C., Helenius, J., Helenius, A. & Rose, J.K.
`1988. Differential effects of mutations in three domains on folding, quarternary
`structure, and intracellular transport of vesicular stomatitis virus G protein. J. Cell
`Biol. 107:89-99.
`67. Guan, J.-L., Ruusala, A., Çao, H. & Rose, J.K. 1988. Effects of altered cytoplasmic do-
`mains on transport of the vesicular stomatitis virus glycoprotein are transferable to
`other proteins. Mol. Cell Biol. 8:2869-2874.
`68. Shaw, A.S., Rottier, P.J.M. & Rose, J.K. 1988. Evidence for the loop model of signal
`sequence insertion into the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA
`85:7592-7596.
`69. Rose, J.K. & Doms, R.W. 1988. Regulation of protein export from the endoplasmic
`reticulum. Ann. Rev. Cell Biol. 4:257-288.
`70. Whitt, M., Chong, L. & Rose, J.K. 1989. Glycoprotein cytoplasmic domain sequences
`required for rescue of the VSV glycoprotein mutant. J. Virol. 63:3569-3578.
`
`Page 6 of 17
`
`

`

`71. Pitta, A.M., Rose, J.K., & Machamer, C.E. A single amino acid substitution elimi-
`nates the stringent carbohydrate requirement for the intracellular transport of a
`viral glycoprotein. J. Virol. 63:3801-3809.
`72. Shaw, A., Amrein, K., Hammond, C., Stern, D.F., Sefton, B.M. & Rose, J.K. 1989. The
`lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glyco-
`protein through its unique amino-terminal domain. Cell 59:627-636.
`73. Brown, D.A., Crise, B., & Rose, J.K. 1989. Mechanism of membrane anchoring af-
`fects polarized expression of two proteins in MDCK cells. Science 245:1499-1501.
`74. Zagouras, P., & Rose, J.K. 1989. Carboxy-terminal SEKDEL sequences retard but do
`not retain two secretory proteins in the endoplasmic reticulum. J. Cell Biol.
`109:2633-2640.
`75. Crise, B., Ruusala, A., Zagouras, P., Shaw, A., & Rose, J.K. 1989. Oligomerization of
`glycolipid-anchored and soluble forms of the vesicular stomatitis virus
`glycoprotein. J. Virol. 63:5328-5333.
`76. Miettinen, H.M., Rose, J.K., & Mellman, I. 1989. Fc receptor isoforms exhibit distinct
`abilities for coated pit localization as a result of cytoplasmic domain heterogeneity.
`Cell 58:317-327.
`77. Shaw A.S., Chalupny J., Whitney J.A., Hammond C., Amrein K.E., Kavathas P.,
`Sefton B.A. & Rose J.K. 1990. Short related sequences in the cytoplasmic domains of
`CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine
`protein kinase. 1990. Mol. Cell Biol. 10:1853-1862.
`78. Machamer, C.E., Doms, R.W., Bole, D.G., Helenius, A. & Rose, J.K. 1990. Heavy
`chain binding protein recognizes incompletely disulfide-bonded forms of vesicular
`stomatitis virus G protein. J. Biol. Chem. 265:6879-6883.
`79. Machamer, C.E., Mentone, S.A., Rose, J.K., Farquhar, M.G. 1990. The E1
`glycoprotein of an avian coronavirus is targeted to the cis Golgi complex.
`Proc.Natl.Acad.Sci.USA 87:6944-6948.
`80. Buonocore, L., & Rose, J.K. 1990. Prevention of HIV-1 glycoprotein transport by
`soluble CD4 retained in the endoplasmic reticulum. Nature 345:625-628.
`81. Crise, B., Buonocore, L., & Rose, J.K. 1990. CD4 is retained in the endoplasmic
`reticulum by the HIV-1 glycoprotein precursor. J. Virol. 64:5585-5593.
`82. Whitt, M.A., Zagouras, P., Crise, B., & Rose, J.K. 1990. A fusion-defective mutant of
`the vesicular stomatitis virus glycoprotein. J. Virol. 64:4907-4913.
`83. Rose, J.K, Buonocore, L., & Whitt, M.A. 1991. A new cationic liposome reagent
`mediating nearly quantitative transfection of animal cells. BioTechniques 10:520-525
`84. Whitt, M.A., Buonocore, L., Rose, J.K., Ciccarone, V., Chytil, A., & Gebeyehu, G.
`1991. TransfectACETM reagent: Transient transfection frequencies >90%. FOCUS
`13:8-12.
`
`Page 7 of 17
`
`

`

`85. Zagouras, P., Ruusala, A., & Rose, J.K. 1991. Dissociation and reassociation of
`oligomeric viral glycoprotein subunits in the endoplasmic reticulum. J. Virol.
`65:1976-1984.
`86. Whitt, M.A., Buonocore, L., Préhaud, C., & Rose, J.K. 1991. Membrane fusion
`activity, oligomerization, and assembly of the rabies virus glycoprotein. Virology
`185:681-689.
`87. Zhang, F., Crise, B., Su, B., Hou, Y., & Rose, J.K., Bothwell, A., Jacobson, K. 1991.
`Lateral diffusion of membrane-spanning and glycosylphosphatidylinositol-linked
`proteins: Toward establishing rules governing the lateral mobility of membrane
`proteins. J. Cell Biol. 115:75-84.
`88. Whitt, M.A., & Rose, J.K. 1991. Fatty acid acylation is not required for membrane
`fusion activity or glycoprotein assembly into VSV virions. Virology 185:875-878.
`89. Brown, D.A., & Rose, J.K. 1992. Sorting of GPI-anchored proteins to glycolipid-en-
`riched membrane subdomains during transport to the apical cell surface. Cell
`68:533-544.
`90. Miettinen, H.M., Matter, K., Hunziker, W., & Rose, J.K., Mellman, I. 1992. Fc
`receptor endocytosis is controlled by a cytoplasmic domain determinant that
`actively prevents coated pit localization. J. Cell Biol. 116:875-888.
`91. Crise B., & Rose, J.K. 1992. Human immunodeficiency virus type 1 glycoprotein
`precursor retains a CD4-p56lck complex in the endoplasmic reticulum. J. Virol.
`66:2296-2301.
`92. Zhang, Z., Crise, B., Su, B., Hou, Y., Rose, J.K., Bothwell, A., Jacobson, K. 1992. The
`lateral mobility of some membrane proteins is determined by their ectodomains.
`Biophys. J. 62:92-94.
`93. Crise, B., & Rose, J.K. 1992. Identification of palmitoylation sites on CD4, the HIV
`receptor. J. Biol. Chem. 267:13593-13597
`94. Locker, J.K., Rose, J.K., Horzinek, M.C., Rottier, P.J. 1992. Membrane assembly of
`the triple-spanning coronavirus M protein: Individual transmembrane domains
`show preferred orientation. J. Biol. Chem. 267:21911-21918.
`95. Owens R.J., & Rose, J.K. 1993. Cytoplasmic domain requirement for incorporation
`of a foreign envelope protein into vesicular stomatitis virus. J. Virol. 68:360-365
`96. Chong, L.D., & Rose, J.K. 1993. Membrane association of functional vesicular
`stomatitis virus matrix protein in vivo. J. Virol. 67:407-414.
`97. Buonocore, L., & Rose, J.K. 1993. Blockade of HIV-1 production in CD4+ T cells by
`an intracellular CD4 expressed under control of the viral long terminal repeat. Proc.
`Natl. Acad. Sci. USA 90:2695-2699.
`98. Doms, R.W., Lamb, R.A., Rose, J.K., & Helenius, A. 1993. Folding and assembly of
`viral membrane proteins. Virology 193:545-562.
`
`Page 8 of 17
`
`

`

`99. Cattaneo, R., & Rose, J.K. 1993. Cell fusion by the envelope glycoproteins of
`persistent measles viruses which caused lethal human brain disease. J. Virol.
`67:1493-1502.
`100. Zagouras, P. & Rose, J.K. 1993. Dynamic equilibrium between vesicular stomatitis
`virus glycoprotein monomers and trimers in the Golgi and at the cell surface. J.
`Virol. 67:7533-7538.
`101. Chong, L.D., & Rose, J.K. 1994. Interaction of normal and mutant vesicular stoma-
`titis virus matrix proteins with the plasma membrane and nucleocapsids. J. Virol.
`68:441-447.
`102. Owens, R.J., Burke, C., & Rose, J.K. 1994. Mutations in the membrane-spanning do-
`main of the human immunodeficiency virus envelope glycoprotein that affect
`fusion activity. J. Virol. 67:570-574
`103. Turi, T.G., Webster, P., & Rose, J.K. Brefeldin A sensitivity and resistance in Schizo-
`saccharomyces pombe: Identification of multiple genes conferring resistance. 1994. J.
`Biol. Chem., 269:24229-24236.
`104. Rodgers, W.A., Crise, B.C., & Rose, J.K. 1994. Signals determining protein tyrosine
`kinase and GPI-anchored protein targeting to a glycolipid-enriched membrane
`fraction. Mol. Cell. Biol. 14:5384-5391
`105. Rolls, M.M,. Webster, P., Balba, N.H., & Rose, J.K. 1994. Novel infectious particles
`generated by expression of the vesicular stomatitis virus glycoprotein from a self-
`replicating RNA. Cell 79:497-506.
`106. Buonocore, L., Turi, T.G., Crise, B., & Rose, J.K. 1994. Stimulation of heterologous
`protein degradation by the Vpu protein of HIV-1 requires the transmembrane and
`cytoplasmic domains of CD4. Virology 204: 482-486.
`107. Lawson, N., Stillman, E.A., Whitt, M.A., & Rose, J.K. 1995. Recombinant vesicular
`stomatitis viruses from DNA. Proc.Natl.Acad.Sci. USA 92: 4477-4481.
`108. Stillman, E. A., Rose, J. K., and Whitt, M. A. (1995). Replication and amplification
`of novel vesicular stomatitis virus minigenomes encoding viral structural proteins.
`J. Virol. 69, 2946-53.
`109. Turi, T. G., and Rose, J. K. (1995). Characterization of a novel Schizosaccharomyces
`pombe multidrug resistance transporter conferring brefeldin A resistance. Biochem
`Biophys Res Commun 213, 410-8.
`110. Kretzschmar, E., Peluso, R., Schnell, M. J., Whitt, M. A., and Rose, J. K. (1996).
`Normal replication of vesicular stomatitis virus without C proteins. Virology 216,
`309-316.
`111. Wagner, R.R. and Rose, J.K. (1996) Rhabdoviridae and their replication. In
`Virology, (Eds. B.N. Fields and D.M. Knipe). Raven Press, New York.
`112. Rolls, M. M., Haglund, K., and Rose, J. K. (1996). Expression of additional genes in
`a vector derived from a minimal RNA virus. Virology 218, 406-411.
`113. Schnell, M. J., Buonocore, L., Whitt, M. A., and Rose, J. K. (1996). The minimal
`conserved transcription stop-start signal promotes stable expression of a foreign
`gene in vesicular stomatitis. J. Virol. 70, : 2318-2323.
`
`Page 9 of 17
`
`

`

`114. Kretzschmar, E., Bui, M., and Rose, J.K. (1996) Membrane association of influenza
`virus matrix protein does not require specific hydrophobic domains or the viral
`glycoproteins. Virology 220 : 37-45.
`115. Schnell, M.J., Buonocore, L., Kretzschmar, E., Johnson, E., and Rose, J.K. (1996)
`Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are
`incorporated efficiently into virus particles. Proc. Natl. Acad. Sci. USA 93: 11359-
`11365.
`116. Degar, S., Johnson, E., Boritz, E., and Rose, J.K. 1996. Replication of primary HIV-1
`isolates is inhibited in PM1 cells expressing sCD4-KDEL. Virology 226:424-429.
`117. Rose, J.K. (1996) Positive strands to the rescue again: A segmented negative-strand
`RNA virus derived from cloned cDNAs. Proc. Natl. Acad. Sci. USA 94: 14998-
`15000.
`118. Johnson, J. E., Schnell, M. J., Buonocore, L., and Rose, J. K. (1997). Specific
`targeting to CD4+ Cells of recombinant vesicular stomatitis viruses encoding
`human immunodeficiency virus envelope proteins. J. Virol. 71, 5060-5068.
`119. Kretzschmar, E., Buonocore, L., Schnell, M. J., and Rose, J. K. (1997). High efficiency
`incorporation of functional influenza virus glycoproteins into recombinant
`vesicular stomatitis viruses. J. Virol. 216:3 09.
`120. Schnell, M. J., Johnson, J. E., Buonocore, L., and Rose, J. K. (1997). Control of HIV-1
`infection by a novel virus specifically targeted to HIV-1-infected cells. Cell. 90: 849-
`857.
`121. Schnell, M.J., Buonocore, L., Boritz, E., Ghosh, H.P., Chernish, R., and Rose, J.K.
`(1998). Requirement for a non-specific glycoprotein cytoplasmic domain sequence
`to drive efficient budding of vesicular stomatitis virus. EMBO J. 17:1289-1296.
`122. Roberts, A.J., Kretzschmar, E., Perkins, A.S., Forman, J, Price, R., Buonocore, L.,
`Kawaoka, Y., and Rose, J.K. (1998) Vaccination with a recombinant vesicular
`stomatitis virus expressing an influenza virus hemagglutinin provides complete
`protection from influenza virus challenge. J. Virol. 72: 4704-4711.
`123. Roberts, A., and Rose, J.K. (1998) Recovery of negative-strand RNA viruses
`fromplasmid DNAs: a positive approach revitalizes a negative field. Virology 247:1-
`6
`124. Johnson, J. E., Rodgers, W., and Rose, J. K. (1998). A plasma membrane localization
`signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of
`vesicular stomatitis virus budding and incorporation into VSV virions. Virology
`251: 244-252.
`125. Kim, S. K., Reed, D. S., Olson, S., Schnell, M. J., Rose, J. K., Morton, P. A., and
`Lefrancois, L. (1998). Generation Of Mucosal Cytotoxic T Cells Against Soluble
`Protein By Tissue-Specific Environmental and Costimulatory Signals. Proc Natl.
`Acad. of Sciences, U. S. A. 95, 10814-10819.
`126. Boritz, E., Gerlach, J., Johnson, J. E., and Rose, J. K. (1999). Replication-competent
`rhabdoviruses with human immunodeficiency virus type 1 coats and green
`fluorescent protein: entry by a pH-independent pathway. J Virol 73, 6937-45.
`
`Page 10 of 17
`
`

`

`127. Kahn, J. S., Schnell, M. J., Buonocore, L., and Rose, J. K. (1999). Recombinant
`vesicular stomatitis virus expressing respiratory syncytial virus (RSV)
`glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology
`254, 81-91.
`128. Roberts, A., Buonocore, L., Price, R., Forman, J., and Rose, J. K. (1999). Attenuated
`vesicular stomatitis viruses as vaccine vectors. J Virol 73, 3723-32.
`129. Roberts, A, and Rose J.K. (1999) Redesign and genetic dissection of the
`rhabdoviruses. Adv. Virus Res. 53: 301-319.
`130. Haglund K, Forman J, Krausslich HG, Rose JK. (2000) Expression of human
`immunodeficiency virus Type 1 Gag protein precursor and envelope proteins from
`a vesicular stomatitis virus recombinant: high-level production of virus-like
`particles containing HIV envelope.Virology 268: 112-121
`131. Schlereth B, Rose JK, Buonocore L, ter Meulen V, Niewiesk S. (2000) Successful
`vaccine-induced seroconversion by single-dose immunization in the presence of
`measles virus-specific maternal antibodies. J Virol. 74:4652-46577.
`132. Grigera PR, Marzocca MP, Capozzo AV, Buonocore L, Donis RO, Rose JK. (2000)
`Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV
`recombinant particles and induction of neutralizing BVDV antibodies in mice.
`Virus Res. 2000 69: 3-15.
`133. Rose NF, Roberts A, Buonocore L, Rose JK. (2000) Glycoprotein exchange vectors
`based on vesicular stomatitis virus allow effective boosting and generation of
`neutralizing antibody to a primary isolate of HIV-1. J. Virol 74:10903-10.
`134. Dalton KP, Rose JK.(2001) Vesicular stomatitis virus glycoprotein containing the
`entire green fluorescent protein on its cytoplasmic domain is incorporated
`efficiently into virus particles. Virology 279:414-421.
`135. Quinones-Kochs, M. I., M. J. Schnell, L. Buonocore, and J. K. Rose. 2001.
`Mechanisms of loss of foreign gene expression in recombinant vesicular stomatitis
`viruses. Virology. 287:427-35.
`136. Rose, J. K., and M. A. Whitt. 2001. Rhabdoviridae: The Viruses and their
`Replication, p. 1221-1244. In D. M. Knipe and P. M. Howley (ed.), Fields Virology,
`4th ed, vol. 1. Lippincott Williams and Wilkins, New York.
`137. Rose, N. F., P. A. Marx, A. Luckay, D. F. Nixon, W. J. Moretto, S. M. Donahoe, D.
`Montefiori, A. Roberts, L. Buonocore, and J. K. Rose. 2001. An effective AIDS
`vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell.
`106:539-49.
`138. Kahn, J.S. , Roberts, A, Weibel, C., Buonocore, L., and Rose, J.K. 2001. Replication-
`competent or attenuated, nonpropagating vesicular stomatitis viruses expressing
`respiratory syncytial virus (RSV) antigens protect mice against RSV challenge. J.
`Virol.. 75:11079-11087.
`139. van den Pol, AN, Dalton, KP and Rose, JK. 2002. Relative neurotropism of a
`recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein. J.
`Virol. 2002. 76: 1309-1327.
`
`Page 11 of 17
`
`

`

`140. Haglund, K., Leiner, I., Kerksiek, K., Buonocore, L., Pamer, E, and Rose, JK. 2002.
`High-level primary CD8+ T Cell response to HIV-1Gag and Env generated by
`vaccination with recombinant vesicular stomatitis viruses. J. Virol. 76:2730-2738.
`141. Quinones-Kochs, M. I., L. Buonocore, and J. K. Rose. 2002. Role of N-linked glycans
`in a human immunodeficiency virus envelope glycoprotein: effects on protein
`function and the neutralizing antibody response. J. Virol. 76: 4199-4211
`142. Buonocore,L, Blight, KJ, Rice, CM and Rose JK. Characterization of vesicular
`stomatitis virus recombinants that express and incorporate high levels of hepatitis
`C virus glycoproteins. J Virol. 2002 76:6865-72.
`143. Haglund, K., Leiner, I., Kerksiek, K., Buonocore, L., Pamer, E, and Rose, JK. 2002.
`Robust recall and long-term memory T-cell responses induced by prime-boost
`regimens with heterologous live viral vectors expressing human immunodeficiency
`virus type 1 Gag and Env proteins. J. Virol. 76:7506-7517.
`144. Reuter JD, Vivas-Gonzalez BE, Gomez D, Wilson JH, Brandsma JL, Greenstone
`HL, Rose JK, Roberts A. (2002) Intranasal vaccination with a recombinant
`vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein
`provides complete protection against papillomavirus-induced disease. J. Virol.
`76:8900-9.
`145. Okuma, K., K. P. Dalton, L. Buonocore, E. Ramsburg, and J. K. Rose. 2003.
`Development of a novel surrogate virus for human T-cell leukemia virus type 1:
`inhibition of infection by osteoprotegerin. J Virol 77:8562-9.
`146. Schlereth, B., L. Buonocore, A. Tietz, V. Meulen Vt, J. K. Rose, and S. Niewiesk.
`2003. Successful mucosal immunization of cotton rats in the presence of measles
`virus-specific antibodies depends on degree of attenuation of vaccine vector and
`virus dose. J Gen Virol 84:2145-51.
`147. Schlehuber, L., and J.K. Rose. 2004. Prediction and identification of a permissive
`epitope insertion site in the vesicular stomatitis virus glycoprotein. J. Virol.
`78:5079-5087.
`148. Roberts, A., Reuter, J.D., Wilson, J.H., Baldwin, S. and Rose, J.K. 2004. Complete
`protection from papillomavirus challenge after a single vaccination with a
`vesicular stomatitis virus vector expressing high levels of L1 protein. J. Virol.,
`78:3196-3199.
`149. Ramsburg, E., Rose, N.F., Marx, P.A, Mefford, M., Nixon, D.F., Moretto, W.J.,
`Montefiori, D., Earl, P.A., Moss, B, and Rose, J.K. 2004. Highly effective control of
`an AIDS virus challenge in macaques using VSV and MVA vectors in a single-
`boost protocol. J. Virol. 78:3196-3199.
`150. Publicover, J., R

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket